DekaBank Deutsche Girozentrale - ARROWHEAD PHARMACEUTICALS IN ownership

ARROWHEAD PHARMACEUTICALS IN's ticker is ARWR and the CUSIP is 04280A100. A total of 161 filers reported holding ARROWHEAD PHARMACEUTICALS IN in Q4 2018. The put-call ratio across all filers is 1.05 and the average weighting 0.1%.

Quarter-by-quarter ownership
DekaBank Deutsche Girozentrale ownership history of ARROWHEAD PHARMACEUTICALS IN
ValueSharesWeighting
Q2 2024$927
-14.1%
36,235
-4.3%
0.00%0.0%
Q1 2024$1,079
-7.6%
37,8440.0%0.00%0.0%
Q4 2023$1,168
+15.2%
37,8440.0%0.00%0.0%
Q3 2023$1,014
-19.1%
37,844
+8.1%
0.00%
-33.3%
Q2 2023$1,253
+47.9%
35,0000.0%0.00%
+50.0%
Q1 2023$847
-69.6%
35,000
-50.0%
0.00%
-71.4%
Q4 2022$2,786
-99.9%
70,0000.0%0.01%0.0%
Q3 2022$2,303,000
-15.5%
70,000
-12.6%
0.01%
-12.5%
Q2 2022$2,724,000
-8.2%
80,050
+23.1%
0.01%
+14.3%
Q1 2022$2,966,000
-10.7%
65,050
+30.0%
0.01%
-12.5%
Q4 2021$3,321,000
+25.2%
50,050
+14.1%
0.01%
+14.3%
Q3 2021$2,653,000
+10.1%
43,850
+46.9%
0.01%0.0%
Q2 2021$2,409,000
+27.5%
29,8500.0%0.01%
+16.7%
Q1 2021$1,890,000
-34.0%
29,850
-19.0%
0.01%
-45.5%
Q4 2020$2,865,000
+47.0%
36,850
-17.6%
0.01%
+22.2%
Q3 2020$1,949,000
+76.1%
44,700
+16.4%
0.01%
+50.0%
Q2 2019$1,107,000
-28.3%
38,400
-64.2%
0.01%
-33.3%
Q1 2019$1,544,000
+36.9%
107,200
+13.8%
0.01%
+28.6%
Q4 2018$1,128,000
-26.9%
94,200
-12.1%
0.01%
-22.2%
Q3 2018$1,544,000
+40.2%
107,200
+26.1%
0.01%
+28.6%
Q2 2018$1,101,00085,0000.01%
Other shareholders
ARROWHEAD PHARMACEUTICALS IN shareholders Q4 2018
NameSharesValueWeighting ↓
ELEMENT CAPITAL MANAGEMENT LLC 142,649$618,0000.25%
ING GROEP NV 808,229$3,500,0000.07%
A.R.T. Advisors, LLC 232,470$1,006,0000.05%
OppenheimerFunds, Inc. 3,000,000$12,990,0000.02%
Edge Wealth Management LLC 10,000$43,0000.01%
First Allied Advisory Services, Inc. 61,000$264,0000.01%
BRIDGEWAY CAPITAL MANAGEMENT, LLC 200,000$866,0000.01%
MILLENNIUM MANAGEMENT LLC 1,272,138$5,508,0000.01%
D. E. Shaw & Co., Inc. 971,768$4,208,0000.01%
Virtu Financial LLC 18,008$78,0000.00%
View complete list of ARROWHEAD PHARMACEUTICALS IN shareholders